Mark Hyman’s Post

THE IMPACT OF PREAUTHORISATION ON HEALTH OUTCOMES IN MEDICAL SCHEMES" MediCheckSA together with the Council for Medical Schemes is delighted to invite you to a webinar on "The Impact of Preauthorisation on Health Outcomes in Medical Schemes" hosted by the Council for Medical Schemes (CMS). 🗓 Date: Thursday, 15 August 2024 🕒 Time: 09:00 – 12:00 📍 Platform: MS Teams Preauthorisation is a crucial process for managing healthcare costs and ensuring appropriate care. It's impact on patient outcomes and overall healthcare quality remains a topic of great interest. This webinar will provide an in-depth exploration of these effects, featuring insights from esteemed industry experts: * Mr. Michael Mncedisi Willie (M.Inst.D) MBA, MSc, MPhil – Executive: Policy, Research, and Monitoring - CMS * Ms. Hannelie Cornelius – Senior Manager: Administrator & MCO Accreditation * Ms. Mumsy Mashilo – Senior Manager: Complaints Adjudication - CMS * Ms. Corlia Koen – Market Analyst: Demacon * Ms. Kelly du Plessis – Founder and CEO: Rare Diseases South Africa * Mr. Mark Hyman – Founder and CEO: MediCheck (KEEPING YOUR MEDICAL AID HONEST) * Dr. Samantha Iyaloo – Public Health Specialist: Policy, Research, and Monitoring - CMS Key Topics to be Discussed by Mr Mark Hyman Balancing cost-containment with quality care Addressing patient and provider concerns regarding preauthorisation 📢 Participation is free! To register for the webinar, please visit Council for Medical Schemes

Advocating for Reform and Dialogue in Regulatory Settings: Driven by a passionate commitment to fostering positive change, Dr. Laura Purdy champions the cause for reform within regulatory environments. Her steadfast belief in the power of dialogue and inclusivity is evident as she shares, "The key to navigating regulatory complexities lies in fostering open conversations and embracing progressive frameworks that cater to the diverse needs of healthcare professionals. By advocating for reform, we pave the way for a more equitable and patient-centric healthcare system." WFXR https://lnkd.in/deZj4pJt

What should healthcare leaders know about clinical variation management (CVM)? Start with this: → Unwarranted clinical variation results in $760B+ in avoidable costs. → Lack of standardization affects consistent care at scale. → Most patients can be cared for using standard, evidence-based practices. This article explains how to reduce variations through better CVM practices. Read to learn: → What causes unwarranted clinical variations → How Monument Health reduced clinical variation → Four recommendations to get variations under control How’s the clinical variation strategy working across your hospital system? See the article if you’re ready for change. https://hubs.li/Q02CT6N-0 #ClinicalVariation #MedicalDevices #ClinicalDataManagement

This is an important piece Lee Fleisher as it calls out a major and solvable barrier to ensuring person-centered care. International Consortium for Health Outcomes Measurement (ICHOM) develops the science based resources collaboratively with clinicians, researchers and people with lived experience to point all of our efforts at outcomes that matter to the patient. Standardizing what and how we measure improvement in clinical and life quality is an essential building block of building the bridge between research and practice.

I have studied healthcare now for over 12 years, and participated with a hospital, East Georgia Regional Medical Center from 2019-2021 as a volunteer with the Chief Quality Officer. It was an education during Covid-19, I witnessed executive management make decisions everyday to provide the best care possible for all 4,000 patients that came through with the virus. We had almost zero PPE, like every hospital in this country, the executive team designed a gown and un-gown process for nurses, only a handful of N-95 masks. My studies for the profession doctorate will study the following: This investigation aims to analyze healthcare data and compare healthcare outcomes quantitatively. For example, available data from the Healthcare Cost and Utilization Project (HCUP), a subsidiary of the Agency for Healthcare Research and Quality (AHRQ), show that readmission rates of 5,238 hospitals around the nation have increased from 18% in 2014 to 32% in 2022, a 44% increase (AHRQ.gov, 2023). This preliminary data shows that despite using an EHR, improved processes, value-added leadership styles, and perfected decision support systems, patients return within 30 days, a quality indicator by CMS and the Joint Commission (Joint Commission, 2023)(CMS.gov, 2023). The purpose of an analysis of healthcare improvement and data optimization from 1972- 2023 is to find quantitative data that improves how hospitals holistically can advance patient outcomes and to what extent an overall plan to amend healthcare. The project will use data from the Agency for Healthcare Research and Quality (AHRQ) on readmissions, ailment, and length of stay data (AHRQ.com, 2023). The researcher will use the era of 1972-2023 to discuss healthcare improvements in quality, patient outcomes, and technology. The reason for this era is that it began during the time of computational magic, as electrifying keystrokes into a visual screen began taking flight. Please advise on any part of this question. Here are three quantitative questions on how to understand the impact of data improvement on healthcare outcomes: 1. How does data improvement affect patient outcomes? Quantitative analysis of patient outcomes such as mortality rates, readmission rates, and length of stay (LOS) can help decide the impact of data improvement on healthcare outcomes. 2. What is the relationship between data improvement and healthcare costs? Quantitative analysis of healthcare costs such as hospitalization, medication, and diagnostic test costs can help decide the relationship between data improvement and healthcare costs. 3. How does data improvement affect healthcare quality? Quantitative analysis of healthcare quality measures such as patient satisfaction scores, clinical quality measures, and safety measures can help find the impact of data improvement on healthcare quality.

Subject: Integrating Care Partners into the Healthcare and Clinical Research Ecosystem Dear Healthcare Industry I would like to bring to your attention a critical aspect of healthcare and clinical trial reform that warrants our focused discussion: the integration of care partners within our healthcare delivery and clinical research frameworks. The evolving landscape of healthcare necessitates a holistic approach that not only enhances patient experiences but also duly recognizes the indispensable role of care partners. Care partners — family members, friends, and volunteers who provide crucial support to patients — are often the unsung heroes in the patient’s healthcare journey. Their contributions, extending from emotional support to assistance with medical care and decision-making, play a pivotal role in the overall health outcomes and quality of life of patients. Yet, despite their significance, the recognition and integration of care partners into the healthcare system and clinical research processes remain underdeveloped. To truly transform our healthcare system into one that is patient-centric and outcome-focused, it is imperative that we acknowledge and incorporate the value care partners bring. This involves developing policies and practices that facilitate their active participation in care planning and decision-making. Additionally, in the realm of clinical research, integrating care partners as stakeholders can provide deeper insights into patient needs, preferences, and the real-world applicability of interventions. The integration of care partners into the healthcare continuum and clinical trial protocols should be systematic, acknowledging their role not just as adjuncts to patient care but as crucial components of the healthcare team. This includes providing them with access to resources, information, and training necessary to support patients effectively. Moreover, our healthcare infrastructure must evolve to offer mechanisms for care partners to communicate with healthcare professionals seamlessly and contribute to the care dialogue. As we deliberate on the future of integrated care systems, I urge the healthcare industry to place significant emphasis on the role of care partners. Recognizing and empowering them is not just an act of acknowledging their contributions; it is a strategic move towards building a more resilient, patient-centered healthcare ecosystem that is capable of delivering superior outcomes. Their integration is pivotal in the seamless transition of care across settings, enhancing patient engagement, adherence to treatment plans, and ultimately, the success of clinical outcomes. #HealthcareInnovation #ClinicalResearch #PatientCenteredCare #FutureOfMedicine #CarePartnerSupport #MedicalBreakthroughs #IntegratedHealthSystems #EmpoweringPatients

It would be remiss of me if I don’t talk about Evidence based practice (EBP) as one of the tenets of improved quality of healthcare 1. Well-informed Decision-Making:  Evidence-based practice (EBP) gives medical practitioners current, trustworthy knowledge derived from extensive scientific study. Evidence-based therapies, treatments, and care plans are selected by healthcare professionals through informed decision-making, resulting in more focused and efficient care. 2. Standardization of Care: Standardized care helps to minimize practice variances, guaranteeing consistency and quality across healthcare facilities and across various healthcare practitioners. Evidence-based practice (EBP) encourages the implementation of standardized procedures and clinical standards established from research evidence. This is seen clearly in practices encouraged by COHSASA and ISQUA 3. Optimal Patient Outcomes: Evidence-based practice (EBP) places emphasis on interventions and therapies that have shown promise in raising patient outcomes. Healthcare practitioners can improve overall patient well-being, minimize problems, and achieve better results by coordinating care using evidence-based practices. 4. Effective Resource Utilization: By identifying the actions that yield the greatest benefits, evidence-based approaches direct resource allocation .This guarantees that time and financial resources are used effectively, resulting in high-quality and reasonably priced care. 5. Continuous Quality Improvement: By encouraging healthcare professionals to periodically assess and adjust their practices in light of new evidence, EBP promotes a culture of continuous quality improvement. Constant evaluation and modification help care procedures change in response to new information.  6. Professional Accountability: EBP upholds healthcare providers' ethical duty to base their decisions on the best available data. It is the responsibility of healthcare practitioners to be up to date on recent research and incorporate new information into their clinical decision-making. 7. Effective Use of Health Information Technology: Real-time access to and application of evidence is made possible by the use of electronic health records (EHRs) and health information technology (HIT) in evidence-based practice (EBP). 8. Research Translation Facilitation: Evidence-based practice (EBP) serves as a link between clinical practice and research findings, making it easier to convert research into interventions that can be implemented. This relationship guarantees that new discoveries in science are successfully applied to routine clinical care. 9. Standardization of Education and Training: Evidence-based practice (EBP) is incorporated into healthcare professional education programs to guarantee that aspiring practitioners are prepared to evaluate and utilize evidence in their work. #qualitycare #qualityhealthcare #cuomoprime #healthcareinnovation #healthcareconsulting #healthcare.

As a GP and Medical Leader, I believe that providing excellent treatment to people with multimorbidity is a challenge that healthcare systems face today and will continue to face in the future. To address this challenge, we need a combination of effective clinical care in General Practice supported by the use of technology. Check out my latest blog post on massiveheart.blog where I delve into this topic in more detail: https://lnkd.in/d22qa3Hy.

Many excellent points in this JAMA article about the disconnect between randomized clinical trials (RCTs) and real-world healthcare delivery. We need to break down the silos impeding the integration of knowledge generation and implementation. One key takeaway: RCTs are still vital. We just need to make it easier to do them in real-world settings. https://lnkd.in/eNxzD9db #HealthcareInnovation #ClinicalTrials #MedicalResearch #HealthSystems #RCTs #HealthcareIntegration #MedicalResearchReform